-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023602-singh-final-report-2017.pdf
January 01, 2017 - test result, a hepatitis B
surface antigen test result that suggested getting an immunization, and a liver … 257.09s)
than either the hepatitis B surface antigen test (M = 100.29 s; SD = 15.22s) or the liver … accounts for the reduced variability in the amount of time participants
took viewing Hepatitis B and liver … their
information needs when it comes to interpreting lipid profile, hepatitis B surface antigen and liver
-
digital.ahrq.gov/sites/default/files/docs/citation/appendix-e-cdspain-sample-clinical-practice-guidelines.docx
October 16, 2020 - comorbidities that increase their risk (mental health disorders, pregnancy, sleep apnea, lung disease, liver
-
digital.ahrq.gov/ahrq-funded-projects/health-information-technology-center-education-and-research-therapeutics
January 01, 2023 - Health Record/Electronic Medical Record , Voice Recognition
Use of hepatotoxic drugs in chronic liver … Use of hepatotoxic drugs in chronic liver disease. J Patient Saf 2012 Jun;8(2):45-50.
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs021747-siegel-final-report-2019.pdf
January 01, 2019 - Gastroenterology and
Hepatology, Charlotte, NC
Jefferson University, Philadelphia, PA Ohio Gastroenterology and Liver … Schlesinger & Fordtran's
Gastrointestinal and Liver Diseases. 7th ed. St.
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs023582-stockwell-final-report-2019.pdf
January 01, 2019 - CMCs include sickle cell disease, cancers, cochlear implants, chronic liver or kidney disease
among … disease such as mild heart valvular disease, heart
surgery in the past, well-controlled kidney or liver
-
digital.ahrq.gov/sites/default/files/docs/citation/healthitandlaborders.pdf
November 01, 2011 - immune
Hep A antibodies Once or until immune
Hep C antibodies Once
RPR (syphilis screen) Once
Liver … 58% 68%
CD4
67%
63%
64%
73%
Lipid profile
84%
89%
87%
93%
Liver
-
digital.ahrq.gov/ahrq-funded-projects/project-echo-extension-community-healthcare-outcomes
January 01, 2023 - who have the disease have been treated in New Mexico, which has the nation's highest rate of chronic liver
-
digital.ahrq.gov/sites/default/files/docs/citation/ereferralimplementationreportfinal.pdf
February 01, 2012 - 0.9
Gastroenterology 229 14.2 50.0 35.4 10.1 25.3 0.4
Hematology 34 10.5 50.2 38.9 7.5 31.4 0.5
Liver … referrals that were “Not Initially
Scheduled” ranged between 9 percent for neurology to 67 percent for liver … proportion of electronic referrals “Never Scheduled” ranged from 4 percent for neurology to
53 percent for liver … MAR09
MAY09
JU
L0
9
Month
D
ay
s
Cardiology
Chest
Endocrinology
Gastroenterology
Hematology
Liver … Liver clinic,
night and day. It used to be 5 months to a year, now it's about 1 to 2 months.”
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs018648-atlas-final-report-2014.pdf
January 01, 2014 - were to monitor treatment efficacy (LDL,
HbA1c) and/or treatment safety (potassium, renal function, liver … prescription were highest for renal
function testing after prescription of an ACE/ARB and lowest for liver
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017817-field-final-report-2012.pdf
January 01, 2012 - 11
connective tissue disease 5 3 0.4705
ulcer disease 17 27 0.0878
mild liver … disease 1 0 0.3161
moderate/severe liver disease 0 0
diabetes mild/moderate 16 20 0.8307
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs028563-final-report-galarraga-2023.pdf
January 01, 2023 - with increased odds of 9-
day ED return include older age, male sex, higher body mass index, having liver … 0.93 0.61
Dementia 0.92 0.63
Diabetes, Type 1 or 2 1.08 0.24
HIV 0.99 0.95
Hypertension 1.05 0.43
Liver
-
digital.ahrq.gov/sites/default/files/docs/citation/EnhancedMedHistoriesImplementationGuide.pdf
November 01, 2011 - Diuretic
• Diuretic, Potassium Sparing
• Diuretic, Potassium Wasting
• Fibrate
• Iron Supplement
• Liver … (miscellaneous drugs with potential for liver enzyme elevation)
• NSAID (Nonsteroidal Anti-inflammatory
-
digital.ahrq.gov/sites/default/files/docs/resource/final-b14-archives-sarkar2075.pdf
January 01, 2013 - (look for terms like ‘metastatic’, ‘stage IV’, palliative chemotherapy, lung
metastis, metastis to liver
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024001-oreskovic-final-report-2019.pdf
January 01, 2019 - Participants, Incidence, Prevalence)
Background
Cardiometabolic disease, including obesity, diabetes, liver
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs026322-dorsch-final-report-2021.pdf
January 01, 2021 - HAS-BLED includes hypertension, abnormal renal
function, abnormal liver function, stroke, prior bleeding
-
digital.ahrq.gov/sites/default/files/docs/workflowtoolkit/IFQHC_operational_redesign_patient_flow_worksheet.pdf
January 01, 2007 - HgbA C for diabetics, EF for CHF patients, amylase/lipase for liver
patients, BUN and creatinines for
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015226-gandhi-final-report-2008.pdf
January 01, 2008 - Medications requiring monitoring by type of laboratory test
Renal Function
Thyroid
Function Liver
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs022666-weckmann-final-report-2016.pdf
January 01, 2016 - including pain scores, body mass index; and laboratory test results
(electrolytes, complete blood count, liver
-
digital.ahrq.gov/sites/default/files/docs/citation/ahrq-cdspain-technical-implementation-guide.pdf
March 01, 2024 - displays information for tapering of non-opioid medications, along with pertinent
laboratory results (liver
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017203-gurwitz-final-report-2011.pdf
January 01, 2011 - considering expanding the 45-day requirement, as it may be too
stringent in a number of instances (e.g., liver